Statistics for Cannara Biotech Inc. (id:1174 LOVE)
Valuation metrics
Market cap
53.11M
Enterprise value
98.33M
Trailing P/E (ttm)
9.83
Forward P/E
PEG ratio
Price/Sales (ttm)
0.69
Price/Book (mrq)
0.65
Enterprise Value/Revenue
1.28
Enterprise Value/EBITDA
6.88
Overview
Shares outstanding
90.02M
Float
43.99M
Shares short
10.00
% Held by insiders
0.49%
% Held by institutions
0.00%
Average volume (10 days)
18.35K
Average volume (90 days)
Price summary
52-Week low
0.52
52-Week high
1.04
52-Week change
-32.35%
Beta
1.07
50-Day moving average
0.65
200-Day moving average
0.75
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
February 13th, 2023
Financials
Fiscal yearFiscal year ends
August 31th, 2023
Most recent quarter (mrq)
May 31th, 2024
Profitability
Profit margin
6.93%
Operating margin
7.75%
Operational effectiveness
Return on assets
3.78%
Return on equity
6.78%
Income statement
Revenue (ttm)
0.85
Revenue per share (ttm)
0.85
Quarterly revenue growth (yoy)
-0.31
Gross profit (ttm)
27.23M
EBITDA
15.84M
Net income to common (ttm)
5.32M
Diluted EPS (ttm)
0.06
Quarterly earnings growth (yoy)
-30.90%
Balance sheet
Total cash (mrq)
5.46M
Total cash per share (mrq)
0.06
Total debt (mrq)
48.88M
Total Debt/Equity (mrq)
59.78
Current ratio (mrq)
231.60%
Book value per share (mrq)
0.91
Cash flow
Cash flow statement
9.91M
Levered free cash flow (LFCF)
-10,362,264.00